Assessment of Cardiometabolic Risks and Associated Factors among Ethiopian Public Health Institute Staff Members
No Thumbnail Available
Date
2018-10
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa Universty
Abstract
Background: - Non communicable diseases are increasingly becoming the global cause of premature death encompassing cardiovascular diseases, cancer, respiratory diseases and diabetes mellitus. Cardiovascular diseases are the major cause of death accounting about nearly half from all deaths by non-communicable diseases as a result of increasing cardiometabolic risks such as insulin resistance, impaired glucose intolerance, dyslipidemia, hypertension and central obesity.
Objective: -Was to assess the magnitude and associated risk factors for cardiometabolic risks among Ethiopian Public Health Institute staffs.
Methodology: - Cross section study design was conducted from January to October 2018 on Ethiopian Public Health Institute staff members using WHO Non-Communicable Diseases (NCD) step survey instrument version 3.1.2008. A total of 450 study participants were involved in this study. The data collection tools were questionnaires, physical measurement and biochemical analysis. The questionnaire was modified with expanded and optional questions like chat chewing to suit local needs. Biochemical analysis were done using COBAS 6000 analyzer. SPSS version 20 was used for statistical data analysis. Ethical clearance was obtained from EPHI Institutional review board (EPHI-IRB) and Addis Ababa University Biochemistry Department ethics and research committee (DRERC).
Results: - The prevalence of metabolic syndrome was 124/450 (27.6%). Prevalence of central obesity, low HDL and hypertension were 80.2%, 41.3% and 23.6% respectively. Likewise, only 24% of the study participants were free from any components of metabolic syndrome and about 40% of the participants had at least two and above components used in metabolic syndrome.
Conclusion: Prevalence of metabolic syndrome was significant in studied population which increases morbidity and premature mortality with CVD and Type 2 DM. Metabolic syndrome will lead to increased cardiometabolic risks causing death from CVD and Type 2 DM. Interventions focused on life style change, nutritional elements and physical activities and early screening are recommended to overcome the disease burden.
Description
Keywords
Metabolic Syndrome, Cardiometabolic Risk, CVD, Type 2 DM, Hypertension, Hyperglycemia, Dyslipidemia, Central Obesity.